Chemi Nutra says its alpha-glyceryl phosphoryl choline (A-GPC) ingredient is well-suited to replace, displace, or augment caffeine in products targeting mental energy, sports nutrition, and healthy aging.
Chemi Nutra (Austin, TX) has filed a novel patent for its alpha-glyceryl phosphoryl choline (A-GPC) ingredient, AlphaSize, which it says is appropriate to replace, displace, or augment caffeine in products targeting mental energy, sports nutrition, and/or healthy aging.
AlphaSize’s research profile currently speaks to potential benefits for reaction, agility, explosive power output, memory, running, and jumping, Chemi Nutra notes. It has been acknowledged as Generally Recognized as Safe by FDA with an agency response letter, Chemi Nutra says, and its lack of taste or odor makes it suitable for foods, beverages, and dietary supplements.
“This patent filing demonstrates Chemi’s commitment to the nutritional supplement and beverage industries, and is supported by research studies that collectively demonstrate how our branded, natural, full GRAS, AlphaSize A-GPC functional ingredients truly impact human performance-both mental and physical,” says Scott Hagerman, president of Chemi Nutra.
Read more:
NeuroActin Awarded Patent For Brain-Health Supplements
Choline Opportunities Are Ripe: Brain, Sports, and More
Natural Ingredients for Energy Dietary Supplements
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.